BRTX vs XLV
BioRestorative Therapies Inc (BRTX) versus Health Care Select Sector SPDR® Fund (XLV) — a side-by-side from cached financials, not a winner call.
BioRestorative Therapies Inc (BRTX) is a biotechnology company listed on NASDAQ.
Health Care Select Sector SPDR® Fund (XLV) common stock listed on US.
Latest reported BRTX revenue for 2025-12-31 was $359.7K. Net income was -$14.2M. Revenue was down 10.3% from 2024-12-31 to 2025-12-31. BRTX currently screens at market cap $10.2M.
XLV does not have a complete income-statement cache yet.
BRTX currently screens at market cap $10.2M. XLV currently screens at market cap $0.
Not investment advice. Open the BRTX and XLV stock pages for the full models.
Not investment advice.